DJI
+0.43%
SPX
+0.27%
IXIC
+0.09%
FTSE
-0.62%
N225
-0.19%
AXJO
-0.11%

CGON Leonard E Post sells $30K worth of shares

Jan 15, 2025, 5:33 AM
-9.06%
What does CGON do
CG Oncology, based in Irvine, California, focuses on developing bladder-sparing therapies for bladder cancer and went public on January 25, 2024. Its key candidates include cretostimogene and BOND-003, both targeting non-muscle invasive bladder cancer.
Leonard E Post sold 1,000 shares of CGON on 13 January at $29.66 per share, worth a total of $30K. They now own 0 CGON shares, or a 100% holding decrease.
📡️ Health Care
Insider Trades

More Signals

Feature in Progress
This section is under development. Check back soon for updates!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

© 2024 Cashu PTY LTD.